Pfizer is latest Big Pharma to overhaul DEI goals after GSK

Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big Pharma after GSK (NYSE:GSK) to revise DEI initiatives amid the Trump administration’s moves to discourage diversity programs.

The U.S. pharma major has now